Welcome to our dedicated page for Trinity Capital news (Ticker: TRIN), a resource for investors and traders seeking the latest updates and insights on Trinity Capital stock.
Trinity Capital Inc. (Nasdaq: TRIN) is an international alternative asset manager focused on private credit, with a portfolio built around secured loans, equipment financings, and related investments in growth-oriented companies. The TRIN news feed on Stock Titan aggregates company-issued press releases, portfolio updates, and financial announcements that reflect how this strategy is being executed over time.
News coverage for Trinity Capital frequently includes quarterly and annual financial results, portfolio activity summaries, and details on new credit facilities or capital markets transactions. For example, the company issues updates on total investment income, net investment income, net asset value, and the composition and risk ratings of its investment portfolio. It also reports on changes to its borrowing arrangements, such as new or expanded credit facilities and term loan agreements with institutional lenders.
Another major component of TRIN news involves transaction announcements with portfolio companies. Trinity Capital regularly discloses commitments of growth capital and equipment financing to businesses in sectors such as life sciences, technology, financial technology, recycling and materials, and consumer products. These releases describe the purpose of the financing and how it supports the counterparties’ expansion, commercialization, or operational scaling plans, while illustrating the application of Trinity Capital’s lending verticals, including Tech Lending, Life Sciences, Asset Based Lending, and Equipment Finance.
Dividend declarations and distribution policies are also recurring topics. Trinity Capital provides information on regular cash dividends, changes in payment frequency, and its intention to distribute a high percentage of taxable income to maintain regulated investment company status. Investors and analysts can use the TRIN news page to follow these developments, track origination and funding volumes, and review management’s commentary on portfolio performance and market opportunities.
Trinity Capital (Nasdaq: TRIN) reported that it originated $773 million of new commitments in Q3 2025, bringing year-to-date new commitments to $1.5 billion through the first three quarters of 2025.
Q3 2025 investments funded totaled approximately $471 million (comprised of $381M secured loans, $57M equipment financings, $33M warrants/equity). Q3 proceeds from repayments and exits were ~$255 million. For the first three quarters, investments funded were ~$1.1 billion and proceeds totaled ~$607 million.
The company will release complete Q3 2025 financial results and host a conference call on November 5, 2025 at 12:00 p.m. ET.
Trinity Capital (Nasdaq: TRIN) appointed Paul D'Agrosa as Managing Director of Life Sciences, based in Denver, effective Oct. 8, 2025.
Mr. D'Agrosa joins to help expand Trinity's Life Sciences platform across new U.S. markets; he brings more than a decade of experience in loan origination, business development, and relationship management. His prior roles include Managing Director at Horizon Technology Finance, where he helped originate more than $140 million in new loan commitments within his first 15 months, and 10 years at Silicon Valley Bank in relationship and credit roles.
The company framed the hire as a step to strengthen life‑sciences lending and source new opportunities across Medtech, Healthtech, Biotech, and Diagnostics/Tools.
Trinity Capital (Nasdaq: TRIN) will report its third quarter 2025 financial results on Wednesday, November 5, 2025 at 8:00 a.m. ET.
The company will host a conference call the same day at 12:00 p.m. ET; participants may dial (800) 267-6316 or (203) 518-9783 internationally and reference Conference ID: TRINQ325. A taped replay will be available about two hours after the call and remain accessible until November 12, 2025 via (800) 753-9146 or (402) 220-2705. A live webcast and a 90-day on‑demand replay will be available on the company's investor relations website at ir.trinitycapital.com.
Trinity Capital (NASDAQ:TRIN) has committed $45 million in growth capital to Rapid Micro Biosystems (NASDAQ:RPID), a life sciences technology company specializing in automation solutions for microbial quality control in healthcare product manufacturing. The funding will support Rapid Micro's global expansion of their Growth Direct® platform and investments in manufacturing efficiency improvements.
The Growth Direct® platform enhances microbial testing processes by providing faster results, improved accuracy, increased operational efficiency, and enhanced data integrity. The capital will be used to scale operations, support commercial expansion, and drive gross margin growth through cost reduction and improved manufacturing efficiency.
AZ-VC has announced the launch of its second venture capital fund, AZ-VC II, following the success of its $115 million Fund I. Led by former PayPal executive Jack Selby, the fund focuses on non-coastal startups, targeting Series A investments in post-revenue companies with proven product-market fit.
The fund is backed by notable Arizona-based limited partners including Pinnacle West Corporation, Western Alliance Bancorp, Trinity Capital (NASDAQ: TRIN), and Salt River Project. AZ-VC's investment strategy capitalizes on an average 70% valuation discount compared to coastal companies with similar metrics, addressing the significant disparity where California, New York, and Massachusetts receive 75% of venture capital despite representing only 22% of the U.S. population.
Trinity Capital (NASDAQ: TRIN) has committed $100 million in growth capital to Angel Studios (NYSE: ANGX), a values-driven entertainment company. This investment follows Angel Studios' recent business combination with Southport Acquisition Corporation and subsequent listing on the NYSE.
Angel Studios operates with a unique model where its 1.5 million Angel Guild members worldwide participate in content selection, effectively acting as virtual co-producers for films and TV shows. The company distributes content through theaters, television, and its streaming platform, focusing on uplifting and values-based entertainment.
Trinity Capital (NASDAQ:TRIN), a leading alternative asset manager, has declared a quarterly cash dividend of $0.51 per share for Q3 2025. The dividend will be paid on October 15, 2025 to shareholders of record as of September 30, 2025.
This marks Trinity's 23rd consecutive quarter of maintaining or increasing its dividend, remaining consistent with the previous quarter's payout. The company aims to distribute 90-100% of its taxable quarterly income through four quarterly dividends to maintain its regulated investment company tax status.
Trinity Capital (NASDAQ:TRIN) has committed up to $50 million in growth funding to Nalu Medical, a commercial-stage medical device company. Nalu specializes in neurostimulation solutions for chronic neuropathic pain through its proprietary implantable pulse generator (IPG) device.
The Nalu Neurostimulation System features a minimally invasive, battery-free micro-IPG device that can be smartphone-controlled. The company recently received FDA clearance for expanded labelling of its Peripheral Nerve Stimulation therapy for whole-body MRI-conditional use, and has published significant long-term real-world data demonstrating reliable pain relief outcomes.
Trinity Capital (NASDAQ:TRIN) has committed $26 million in growth capital to Unmind, a workplace mental health platform. The funding will support Unmind's expansion, development of its AI agent Nova, talent acquisition, and innovation initiatives.
Unmind's platform provides comprehensive mental health solutions including AI guidance, therapy, coaching, crisis care, and wellbeing tracking. The company currently serves nearly 3 million employees worldwide. This latest funding, combined with previous rounds including Series C, brings Unmind's total capital raised to over $100 million.
Trinity Capital Inc. (NASDAQ: TRIN) has announced a $15 million growth capital commitment to TQA, a leader in agentic automation and AI consulting. TQA, founded in 2020 and headquartered in Austin, Texas, specializes in agentic AI, intelligent automation, and data services across multiple industries including healthcare, life sciences, aviation, and financial services.
The funding will support TQA's global expansion and development of new industry-disrupting technologies. fitcapital, LLC served as TQA's exclusive debt advisor for this transaction. Trinity Capital, which has deployed over $4.7 billion across 420+ investments since 2008, continues its strategy of investing in growth-oriented companies through various lending verticals.
FAQ
What is the current stock price of Trinity Capital (TRIN)?
What is the market cap of Trinity Capital (TRIN)?
